ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of gene expression, announced today its participation in the 8th Annual ...

Amgen announced that Tepezza (teprotumumab [Genetical Recombination]) was approved by Japan's Ministry of Health, Labour and Welfare to treat active thyroid eye disease (TED) or TED with a high ...

Amgen yesterday revealed that Tepezza (teprotumumab [genetical recombination]) has been approved for the treatment of active ...

Amgen (NASDAQ:AMGN) today announced TEPEZZA® (JAN: Teprotumumab (Genetical Recombination)) has been approved for the treatment of active or high ...

Japan’s MHLF approves Padcev with Keytruda for first-line treatment of radically unresectable urothelial carcinoma: Tokyo Wednesday, September 25, 2024, 11:00 Hrs [IST] Astellas ...

Amgen (NASDAQ:AMGN) today announced TEPEZZA® (JAN: Teprotumumab (Genetical Recombination)) has been approved for the ...

In a news packed morning, Japanese drugmaker Astellas Pharma (TYO: 4503) today revealed two regulatory approvals.

Nine Entertainment’s Olympic torch-bearing CEO Mike Sneesby is not the only ASX corporate chieftain to hand over the baton ...

The great increase in genetical research and the marked desire of many geneticists to link their studies with other aspects of biology is, however, leading to renewed interest in the taxonomic and ...

Without labelling requirements for food made from a new class of 'GMO-lite' crops, consumers will be deprived of choice and ...

Pokobxý, V. Gichner, T. Krekule, J. Seidlová, Frtdeta Šetlík, I. and Tichá, Ingrid 1978. Book reviews. Biologia Plantarum, Vol. 20, Issue. 1, p. 73.

Genetical and protein biomarkers identifying individuals at risk of developing HPV and EBV infections and associated cancer forms are assessed. Moreover, how the transition of a traditional African ...